HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 12-10-2005, 07:43 AM   #1
Joe
Webmaster
 
Joe's Avatar
 
Join Date: Feb 2005
Location: Home of the "Flying Tomato" Carlsbad, CA
Posts: 2,036
Images: 5
To Patty Z

The following trial may be of interest to you:

Regards
Joe




Brain Metastases in ErbB2-Positive Breast Cancer
This study is currently recruiting patients.
Verified by GlaxoSmithKline December 2005

Sponsored by:GlaxoSmithKlineInformation provided by:GlaxoSmithKlineClinicalTrials.gov Identifier:NCT00263588
Purpose

The purpose of this study is to determine how safe and effective lapatinib is when used to treat patients with ErbB2 overexpressing breast cancer that has spread to the brain and is still progressing there even after radiation treatment using WBRT (whole brain radiotherapy) or SRS (stereotactic radiosurgery) to the brain. Lapatinib is an oral drug that will be taken every day. Tests for safety and efficacy will be performed every 4 weeks or 8 weeks (depending on the test) during the course of the study.
Condition InterventionPhaseMetastatic Breast Cancer
Drug: lapatinib
Phase II

MedlinePlus related topics: Breast Cancer; Cancer
Genetics Home Reference related topics: breast cancer

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Official Title: A Phase II Study of Lapatinib for Brain Metastases in Subjects With ErbB2-Positive Breast Cancer Following Trastuzumab-Based Systemic Therapy and Cranial Radiotherapy

Further Study Details:
Primary Outcomes: To determine the response to lapatinib in patients with progressive brain metastases from ErbB2-overexpressing breast cancer.
Secondary Outcomes: No secondary outcomes
Expected Total Enrollment: 220
Study start: November 2005


Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
  • <LI style="MARGIN-TOP: 2px">Signed Informed Consent
  • ErbB2(HER2)overexpressing breast cancer.
  • Brain lesion(s) which are progressing.
  • Prior treatment of brain metastases with Whole Brain Radiotherapy (WBR)and/or Stereotactic Radiosurgery (SRS).
  • Prior treatment with trastuzumab (Herceptin), either alone or in combination with chemotherapy.
  • Cardiac ejection fraction(LVEF)within the institutional range of normal as measured by Echocardiogram.
  • Able to swallow an oral medication.
  • Adequate kidney and liver function.
  • Adequate bone marrow function.
Exclusion criteria:
  • <LI style="MARGIN-TOP: 2px">Pregnant or lactating females.
  • Conditions that would effect the absorption of an oral drug.
  • History of immediate or delayed hypersensitivity reaction to gadolinium contrast agents.
  • Pre-existing severe cerebral vascular disease, such as stroke involving a major vessel.
  • Serious medical or psychiatric disorder that would interfere with the patient's safety or informed consent.
Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier NCT00263588


GSK Clinical Trials Call Center: Refer to Study "EGF105084" 1-877-379-3718


Alabama
GSK Clinical Trials Call Center, Birmingham, Alabama, 35205, United States; Recruiting James Cantrell 877-379-3718 lisa.moore@usoncology.com


Arizona
GSK Clinical Trials Call Center, Sedona, Arizona, 86336, United States; Recruiting Deborah Lindquist 877-379-3718


GSK Clinical Trials Call Center, Tuscon, Arizona, 85724-5024, United States; Not yet recruiting Allison Stopeck 877-379-3718


California
GSK Clinical Trials Call Center, Vallejo, California, 94589, United States; Not yet recruiting Louis Fehrenbacher 877-379-3718 desiree.goldstein@kp.org


GSK Clinical Trials Call Center, Long Beach, California, 90813-3244, United States; Not yet recruiting Andre Liem 877-379-3718 andrel@pacshoresoncology.com


GSK Clinical Trials Call Center, Northridge, California, 91328, United States; Not yet recruiting Sheldon Davidson 877-379-3718 sheljdavid@aol.com


GSK Clinical Trials Call Center, Redondo Beach, California, 90277, United States; Not yet recruiting David Chan 877-379-3718 Cca.rb@verizon.net


GSK Clinical Trials Call Center, San Francisco, California, 94115, United States; Not yet recruiting Michelle Melisko 877-379-3718 Lauren.Metzroth@ucsfmedctr.org


GSK Clinical Trials Call Center, Los Angeles, California, 90095-1678, United States; Not yet recruiting Mark Pegram 877-379-3718 pocandela@mednet.ucla.edu


GSK Clinical Trials Call Center, Bakersfield, California, 93309, United States; Not yet recruiting Ravi Patel 877-379-3718 lgood@cbccusa.com


GSK Clinical Trials Call Center, Pomona, California, 91767, United States; Not yet recruiting Linda Bosserman 877-379-3718 linda.bosserman@womgi.com


GSK Clinical Trials Call Center, Santa Barbara, California, 93105, United States; Not yet recruiting Frederic Kass 877-379-3718 Fkass@ccsb.org


GSK Clinical Trials Call Center, Fullerton, California, 92835, United States; Not yet recruiting Richard E. Lloyd 877-379-3718 rlloyd@sjf.stjoe.org


GSK Clinical Trials Call Center, Alhambra, California, 91801, United States; Not yet recruiting Eddie Hu 877-379-3718 eddiehu@pacbell.net


Colorado
GSK Clinical Trials Call Center, Denver, Colorado, 80220, United States; Recruiting Devchand Paul 877-379-3718


District of Columbia
GSK Clinical Trials Call Center, Washington, District of Columbia, 20007, United States; Recruiting Minetta Liu 877-379-3718 liumc@georgetown.edu


Florida
GSK Clinical Trials Call Center, Jacksonville, Florida, 32224-1865, United States; Not yet recruiting Edith Perez 877-379-3718 bailey.elizabeth@mayo.edu


GSK Clinical Trials Call Center, Plantation, Florida, 33324, United States; Not yet recruiting Charles Vogel 877-379-3718 drcvogel@aol.com


Georgia
GSK Clinical Trials Call Center, Athens, Georgia, 30607, United States; Not yet recruiting R. Glen Wiggans 877-379-3718


Illinois
GSK Clinical Trials Call Center, Chicago, Illinois, 60611, United States; Not yet recruiting William Gradishar 877-379-3718 a-sheerer2@northwestern.edu


Indiana
GSK Clinical Trials Call Center, Indianapolis, Indiana, 46202, United States; Not yet recruiting Anna Maria Storniolo 877-379-3718 astornio@iupui.edu


GSK Clinical Trials Call Center, Indianapolis, Indiana, 46227, United States; Recruiting David Loesch 877-379-3718 sara.campbell@usoncology.com


Iowa
GSK Clinical Trials Call Center, Sioux City, Iowa, 51101, United States; Not yet recruiting Stephen Kahanic 877-379-3718 shoaresearch@shoa-research.com


Kansas
GSK Clinical Trials Call Center, Kansas City, Kansas, 66160, United States; Not yet recruiting Carol Fabian 877-379-3718 rclark-snow@kumc.edu


Maryland
GSK Clinical Trials Call Center, Baltimore, Maryland, 21231, United States; Not yet recruiting Antonio Wolff 877-379-3718 sjeter1@jhmi.edu


Massachusetts
GSK Clinical Trials Call Center, Boston, Massachusetts, 02115, United States; Not yet recruiting Nancy Lin 877-379-3718 khurtley@bidmc.harvard.edu


Michigan
GSK Clinical Trials Call Center, Ann Arbor, Michigan, 48109-0942, United States; Not yet recruiting Daniel F. Hayes 877-379-3718 jhayden@umich.edu


Minnesota
GSK Clinical Trials Call Center, Minneapolis, Minnesota, 55455, United States; Not yet recruiting Douglas Yee 877-379-3718 gayxx001@umn.edu


GSK Clinical Trials Call Center, Minneapolis, Minnesota, 55404, United States; Recruiting Patrick Flynn 877-379-3718


Missouri
GSK Clinical Trials Call Center, St. Louis, Missouri, 63110, United States; Not yet recruiting Michael Naughton 877-379-3718 mellis@im.wustl.edu


Nevada
GSK Clinical Trials Call Center, Las Vegas, Nevada, 89109, United States; Not yet recruiting Heather Allen 877-379-3718 Heather.Allen@unoncology.com


GSK Clinical Trials Call Center, Henderson, Nevada, 89052, United States; Not yet recruiting Paul E. Michael 877-379-3718 pmichael@usoncolgy.com


New Mexico
GSK Clinical Trials Call Center, Albuquerque, New Mexico, 87131, United States; Not yet recruiting Melanie Royce 877-379-3718 tstewart@nmcca.org


New York
GSK Clinical Trials Call Center, New York, New York, 10021-6007, United States; Not yet recruiting Monica Fornier 877-379-3718


North Carolina
GSK Clinical Trials Call Center, Chapel Hill, North Carolina, 27599, United States; Not yet recruiting Lisa Carey 877-379-3718 lisa_carey@med.unc.edu


Pennsylvania
GSK Clinical Trials Call Center, Philadelphia, Pennsylvania, 19104-4283, United States; Not yet recruiting Angela DeMichele 877-379-3718 angela.klem@uphs.upenn.edu


GSK Clinical Trials Call Center, Pittsburg, Pennsylvania, 15213, United States; Not yet recruiting Adam Brufsky 877-379-3718 clearydl@upmc.edu


Tennessee
GSK Clinical Trials Call Center, Nashville, Tennessee, 37203, United States; Not yet recruiting Denise Yardley 877-379-3718 hburris@tnonc.com


Texas
GSK Clinical Trials Call Center, Dallas, Texas, 75246, United States; Recruiting Joanne Blum 877-379-3718


GSK Clinical Trials Call Center, Houston, Texas, 77030, United States; Not yet recruiting Jenny Chang 877-379-3718 taraj@breastcenter.tmc.edu


GSK Clinical Trials Call Center, San Antonio, Texas, 78258, United States; Not yet recruiting Gladys Rodriguez 877-379-3718


GSK Clinical Trials Call Center, Tyler, Texas, 75702, United States; Recruiting Donald Richards 877-379-3718


Washington
GSK Clinical Trials Call Center, Seattle, Washington, 98109-1023, United States; Not yet recruiting Hannah Linden 877-379-3718 mitraz@u.washington.edu


GSK Clinical Trials Call Center, Yakima, Washington, 98902, United States; Recruiting Vicky Jones 877-379-3718 Beth.Parker@usoncology.com


Belgium
GSK Clinical Trials Call Center, Brussels, 01000, Belgium; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


France
GSK Clinical Trials Call Center, Toulouse, 31052, France; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


GSK Clinical Trials Call Center, Paris, 75248, France; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


GSK Clinical Trials Call Center, Dijon, 21079, France; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


GSK Clinical Trials Call Center, Paris, 75475, France; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


Greece
GSK Clinical Trials Call Center, Athens, 115 26, Greece; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


Italy
GSK Clinical Trials Call Center, Perugia, 06132, Italy; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


GSK Clinical Trials Call Center, Milano, 20141, Italy; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


Sweden
GSK Clinical Trials Call Center, Uppsala, 751 85, Sweden; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718


United Kingdom
GSK Clinical Trials Call Center, Manchester, M20 4BX, United Kingdom; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718





Study chairs or principal investigators

GSK Clincial Trials, MD, Study Director, GlaxoSmithKline
Joe is offline   Reply With Quote
Old 12-10-2005, 08:21 AM   #2
pattyz
Guest
 
Posts: n/a
Thanks, Joe. I appreciate this. The U of MN is only about an hr away. I'll make sure I take this info to my onc next appt.

Best wishes,
pattyz
  Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 09:26 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter